Neurochemistry/Neuropharmacology of Fear and Fear Conditioning
Over the last 20 years, research on emotion has enjoyed a resurgence in the neurosciences. Nowhere has this been more evident than in the fear system of the brain. In this chapter, we discuss the brain's “fear learning” system from a neurochemical and pha
- PDF / 476,031 Bytes
- 19 Pages / 467.716 x 710.929 pts Page_size
- 28 Downloads / 248 Views
Neurochemistry/ Neuropharmacology of Fear and Fear Conditioning
G. E. Schafe . J. E. LeDoux
1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 690 1.1 The Amygdala and Fear Conditioning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 691 2 Neurochemical Mechanisms of Fear Memory Formation: The Importance of LTP . . . . . . . . . . . . 692 2.1 Early‐LTP Versus Late‐LTP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 692 3 3.1 3.2 3.3 3.4
Neurochemical Mechanisms Underlying Acquisition and STM Formation of Fear Conditioning in the Amygdala . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 693 NMDA Receptors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 693 Metabotropic Glutamate Receptors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 694 Ca2þ/Calmodulin‐Dependent Protein Kinase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 696 AMPA Receptor Regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 696
4 4.1 4.2 4.3
Neurochemical Mechanisms of LTM Formation in the Amygdala . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 696 L‐type VGCCs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 697 Protein Kinase A and Mitogen‐Activated Protein Kinase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 697 Transcriptional Regulation and Macromolecular Synthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 698
5
A Model of Fear Memory Acquisition and Consolidation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 701
6
Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 702
#
Springer-Verlag Berlin Heidelberg 2007
690
18
Neurochemistry/neuropharmacology of fear and fear conditioning
Abstract: Over the last 20 years, research on emotion has enjoyed a resurgence in the neurosciences. Nowhere has this been more evident than in the fear system of the brain. In this chapter, we discuss the brain’s ‘‘fear learning’’ system from a neurochemical and pharmacological perspective. We focus on the neurochemical and biochemical
Data Loading...
